Synbio Tech Inc.

Research Synbio Tech Inc. (1295.TWO) on Bullrun: market cap TWD 1.82B, P/E 11.8, dividend yield 6.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 1.82B; P/E is 11.8; dividend yield is 6.2%.

Peer valuation comparison

Latest P/E is 11.79x versus a Healthcare sector median of 21.74x (45.8% below).

Latest dividend yield is 6.19% versus a Healthcare sector median of 2.4% (157.9% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 1.82B11.86.2%2.99

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.99 TWD, yield 6.2%.

About Synbio Tech Inc.

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Synbio Tech Inc.'s market cap?

Synbio Tech Inc.'s market capitalization is TWD 1.82B.

What is Synbio Tech Inc.'s P/E ratio?

Synbio Tech Inc.'s price-to-earnings (P/E) ratio is 11.8.

Does Synbio Tech Inc. pay a dividend?

Synbio Tech Inc. has a dividend yield of 6.2%.

What does Synbio Tech Inc. do?

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain.